PMGC Holdings, Inc. (ELAB)
2.77
-0.27
(-8.88%)
USD |
NASDAQ |
Oct 16, 16:00
2.90
+0.13
(+4.69%)
After-Hours: 20:00
PMGC Holdings Shareholders Equity (Quarterly) : 16.74M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 16.74M |
| March 31, 2026 | 12.61M |
| December 31, 2025 | 7.837M |
| September 30, 2025 | 8.491M |
| June 30, 2025 | 9.049M |
| March 31, 2025 | 8.128M |
| December 31, 2024 | |
| September 30, 2024 | 8.555M |
| Date | Value |
|---|---|
| June 30, 2024 | 2.640M |
| March 31, 2024 | 2.486M |
| December 31, 2023 | 3.827M |
| September 30, 2023 | -0.1639M |
| June 30, 2023 | |
| March 31, 2023 | |
| December 31, 2022 | 1.131M |
| September 30, 2022 | 1.131M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Zivo Bioscience, Inc. | -3.382M |
| Shonghoya Intl Group, Inc. | -0.0059M |
| TFA Therapeutics, Inc. | -- |
| Arcadia Biosciences, Inc. | 0.633M |
| CCA Industries, Inc. | 3.505M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 36.56M |
| Total Liabilities (Quarterly) | 19.83M |
| Debt to Equity Ratio | 0.8507 |
| Current Ratio | 1.359 |
| Net Debt Paydown Yield | -382.7% |